Braskem S.A. Files October 2025 6-K Report
Ticker: BAK · Form: 6-K · Filed: Oct 14, 2025 · CIK: 1071438
Sentiment: neutral
Topics: reporting, foreign-private-issuer, sec-filing
TL;DR
BRASKEM SA filed a 6-K on 10/14/25, confirming its foreign private issuer status and 20-F filing.
AI Summary
Braskem S.A. filed a Form 6-K on October 14, 2025, for the month of October 2025. The filing is a report of a foreign private issuer and indicates that Braskem S.A. files annual reports under Form 20-F. The company's principal executive offices are located in Camacari, Bahia, Brazil.
Why It Matters
This filing serves as an update for investors and regulatory bodies regarding Braskem S.A.'s status as a foreign private issuer and its reporting obligations.
Risk Assessment
Risk Level: low — This filing is a routine procedural report and does not contain new financial or operational information that would typically indicate significant risk.
Key Players & Entities
- BRASKEM S.A. (company) — Filer of the 6-K report
- October 14, 2025 (date) — Filing date of the 6-K
- Camacari, Bahia, Brazil (location) — Location of principal executive offices
- Form 20-F (document) — Annual report form filed by the registrant
- Form 6-K (document) — Type of report filed
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934. It is used to furnish information which the registrant may be required to make public pursuant to the laws of its home country, or which it may be required to file with a stock exchange on which it has been listed, or which it may propose to make or has made public.
What does it mean that Braskem S.A. is a foreign private issuer?
As a foreign private issuer, Braskem S.A. is subject to different reporting and regulatory requirements under U.S. securities laws compared to domestic U.S. companies. For example, it files annual reports on Form 20-F instead of Form 10-K.
When was this specific Form 6-K filed?
This Form 6-K was filed on October 14, 2025.
Where are Braskem S.A.'s principal executive offices located?
Braskem S.A.'s principal executive offices are located at Rua Eteno, 1561, Polo Petroquimico de Camacari, Camacari, Bahia - CEP 42810-000, Brazil.
Does Braskem S.A. file annual reports under Form 20-F?
Yes, the filing explicitly indicates with a checkmark that Braskem S.A. files annual reports under Form 20-F.
Filing Stats: 4,437 words · 18 min read · ~15 pages · Grade level 14.3 · Accepted 2025-10-14 06:07:32
Filing Documents
- bak20251013_6k2.htm (6-K) — 317KB
- bak202510136k2_001.jpg (GRAPHIC) — 12KB
- 0001292814-25-003528.txt ( ) — 336KB
From the Filing
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of October, 2025 (Commission File No. 1-14862 ) BRASKEM S.A. (Exact Name as Specified in its Charter) N/A (Translation of registrant's name into English) Rua Eteno, 1561, Polo Petroquimico de Camacari Camacari, Bahia - CEP 42810-000 Brazil (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ___X___ Form 40-F ______ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1). _____ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7). _____ Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes ______ No ___X___ If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _____. BRASKEM S.A. National Register of Legal Entities (CNPJ) No. 42.150.391/0001-70 A Publicly Held Company MANAGEMENT PROPOSAL FOR THE EXTRAORDINARY GENERAL MEETING OF BRASKEM S.A. TO BE HELD ON NOVEMBER 13, 2025 Dear Shareholders, The Management of Braskem S.A. (“ Company ” or “ Braskem’ ”) hereby submits a proposal (“ Proposal ”) in relation to the matters contained in the agenda of Braskem’s Extraordinary General Meeting, to be held on November 13, 2025, at 3:00 p.m., in an exclusively digital manner, pursuant to article 5, paragraph 2, item I, and article 28, paragraphs 1, 2 and 3 of Brazilian Securities Commission (“ CVM ”) Resolution No. 81, of March 29, 2022 (“ CVM Resolution 81 ”), through digital platform Webex (“ Digital Platform ” and “ Meeting ”, respectively)). The Company clarifies that, pursuant to article 9, sole paragraph, of the Bylaws, Class “A” and “B” preferred shares shall be entitled to vote at this Meeting and shall vote jointly with the common shares on the resolutions regarding the matters on the Agenda. 1. Replacement of one (1) effective member of the Company’s Board of Directors appointed by Novonor S.A. – Under Judicial Reorganization (“Novonor”) and by NSP Investimentos S.A. – Under Judicial Reorganization (“NSP Inv.”), to complete the remaining term of office, until the Annual General Meeting that will resolve on the Company’s financial statements for the fiscal year ending on December 31, 2025 Considering the resignation submitted by Mr. Roberto Faldini from his position as an Effective Member of the Company’s Board of Directors, the Company’s Management submits to the shareholders the resolution on the election, as indicated by Novonor and NSP Inv. pursuant to Item 3.2.2 (a) of Braskem’s Shareholders’ Agreement, of Mr. Lucas Cive Barbosa as an Effective Member of the Company’s Board of Directors, replacing Mr. Roberto Faldini, who was also appointed by Novonor and NSP Inv. The effective member will be elected to complete the current term, which will end at the Annual General Meeting that will review the financial statements for the fiscal year ending December 31, 2025 (“ AGM 2026 ”). Annex I to this Proposal contains information about the candidate for Effective Member of the Board of Directors (“ BoD ”) nominated by shareholders Novonor and NSP Inv., as well as his professional experience, pursuant to items 7.3 to 7.6 of the Reference Form, in compliance with Article 11, item I, of CVM Resolution 81. Impossibility of Separate Election or Multiple Vote In line with the understanding of the CVM Board, considering that the Meeting is being convened for the replacement of one (1) effective member of the Company’s Board of Directors, elected by majority vote, there will be no possibility of adopting separate election, as provided for in paragraphs 4 and 5 of Article 141 of Law No. 6,404 of December 15, 1976 (“ Brazilian Corporations Law ”), nor will multiple vote be applicable. 2. Amendment to article 2 of the Company's Bylaws, to improve its wording by aligning the description of the corporate purpose with the current reality of the activities performed by the Company The Management of the Company proposes to the Shareholders the resolution regarding the amendment of article 2 of the Company's Bylaws, in order to improve its wording, adapting the text of the corporate purpose to the current reality of the activities carried out by the Company, a